Eleclazine HydrochlorideProduct ingredient for Eleclazine
- Name
- Eleclazine Hydrochloride
- Drug Entry
- Eleclazine
Eleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others.
- Accession Number
- DBSALT002187
- Structure
- Synonyms
- Not Available
- UNII
- 4R1JP3Q4HI
- CAS Number
- 1448754-43-5
- Weight
- Average: 451.83
Monoisotopic: 451.0910536 - Chemical Formula
- C21H17ClF3N3O3
- InChI Key
- ZRYHNOXHGYUHFF-UHFFFAOYSA-N
- InChI
- InChI=1S/C21H16F3N3O3.ClH/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19;/h1-9,12H,10-11,13H2;1H
- IUPAC Name
- 4-[(pyrimidin-2-yl)methyl]-7-[4-(trifluoromethoxy)phenyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one hydrochloride
- SMILES
- Cl.FC(F)(F)OC1=CC=C(C=C1)C1=CC=C2OCCN(CC3=NC=CC=N3)C(=O)C2=C1
- External Links
- ChemSpider
- 34984779
- Predicted Properties
Property Value Source Water Solubility 0.019 mg/mL ALOGPS logP 3.29 ALOGPS logP 4.35 Chemaxon logS -4.3 ALOGPS pKa (Strongest Basic) 0.6 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 64.55 Å2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 98.42 m3·mol-1 Chemaxon Polarizability 39.45 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon